Jennifer L. Mason
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jennifer L. Mason has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Adam Resnick
Center for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia
1 shared publication Alex Sickler
1 shared publication- Alice C. Ortmann
Bedford Institute of Oceanography, Fisheries and Oceans Canada , 1 Challenger Drive, Dartmouth, Nova Scotia, B2Y 4A2
1 shared publication Alison Gladwell
Dalhousie University, 6299 South Street, Halifax, NS B3H 4R2, Canada
1 shared publicationAliza P. Cohen
Division of General and Thoracic Pediatric Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
1 shared publication- Allison P. Heath
Children's Hospital of Philadelphia, Philadelphia, PA
1 shared publication
Latest Publications
- Open Access
Germline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors
The contribution of rare pathogenic/likely pathogenic (P/LP) germline variants to pediatric central nervous system (CNS) tumor development remains understudied. Here, we characterized the prevalence and clinical significance of germline P/LP variants in cancer predisposition genes across 830 CNS tumor patients from the Pediatric Brain Tumor Atlas (PBTA). We identified germline P/LP variants in 23.3% (193/830) of patients and the majority (137/193) lacked clinical reporting of genetic tumor syndromes. Among P/LP carriers, 34.6% had putative somatic second hits or loss of function tumor alterations. Finally, we linked pathogenic germline variation with novel somatic events and patient survival to highlight the impact of germline variation on tumorigenesis and patient outcomes.
Open AccessGermline pathogenic variation impacts somatic alterations and patient outcomes in pediatric CNS tumors
The contribution of rare pathogenic/likely pathogenic (P/LP) germline variants to pediatric central nervous system (CNS) tumor development remains understudied. Here, we characterized the prevalence and clinical significance of germline P/LP variants in cancer predisposition genes across 830 CNS tumor patients from the Pediatric Brain Tumor Atlas (PBTA). We identified germline P/LP variants in 23.3% (193/830) of patients and the majority (137/193) lacked clinical reporting of genetic tumor syndromes. Among P/LP carriers, 34.6% had putative somatic second hits or loss of function tumor alterations. Finally, we linked pathogenic germline variation with novel somatic events and patient survival to highlight the impact of germline variation on tumorigenesis and patient outcomes.
- Open Access
- 1 April 2020
- Published by Elsevier in Marine Pollution Bulletin
- Vol. 153, 111003
Measuring the fate of different diluted bitumen products in coastal surface waters
- 1 April 2020
- Published by Elsevier in Marine Pollution Bulletin
- Vol. 153, 111003
Open AccessMeasuring the fate of different diluted bitumen products in coastal surface waters
- 1 July 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (7) , 1279-1284
Lymphatic malformations of the tongue base
- 1 July 2006
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 41 (7) , 1279-1284
Lymphatic malformations of the tongue base
- 1 March 1995
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 665 (2) , 410-415
Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography
- 1 March 1995
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 665 (2) , 410-415
Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography